Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Equity Ratio (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Equity Ratio data on record, last reported at 0.28 in Q4 2025.

  • For Q4 2025, Equity Ratio fell 14.57% year-over-year to 0.28; the TTM value through Dec 2025 reached 0.28, down 14.57%, while the annual FY2025 figure was 0.28, 14.57% down from the prior year.
  • Equity Ratio reached 0.28 in Q4 2025 per MRVI's latest filing, down from 0.29 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.55 in Q1 2025 and bottomed at 0.16 in Q1 2021.
  • Average Equity Ratio over 5 years is 0.38, with a median of 0.38 recorded in 2022.
  • Peak YoY movement for Equity Ratio: soared 133.45% in 2021, then tumbled 39.7% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.28 in 2021, then soared by 39.51% to 0.4 in 2022, then skyrocketed by 33.88% to 0.53 in 2023, then crashed by 39.24% to 0.32 in 2024, then fell by 14.57% to 0.28 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.28 in Q4 2025, 0.29 in Q3 2025, and 0.52 in Q2 2025.